Ignite Creation Date:
2024-05-06 @ 1:16 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03970382
Status:
SUSPENDED
Last Update Posted:
2022-08-18
First Post:
2019-05-06
Brief Title:
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Sponsor:
PACT Pharma Inc
Organization:
PACT Pharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
Keywords:
| Name | View |
|---|---|
| IL-2 | View |
| melanoma | View |
| HR breast cancer | View |
| ovarian cancer | View |
| prostate cancer | View |
| colorectal cancer | View |
| urothelial carcinoma | View |
| adoptive cell therapy | View |
| neoantigen | View |
| T cell receptor | View |
| T lymphocyte | View |
| TCR-engineered T cells | View |
| personalized cell therapy | View |
| cell therapy | View |
| immunotherapy | View |
| gene therapy | View |
| PD-1 | View |
| non-small cell lung cancer | View |
| head and neck squamous carcinoma | View |
| HER2 negative breast cancer | View |
| triple negative breast cancer | View |